We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The Power of Positrons: PET/CT Advances Preclinical Pharmaceutical Research

Industry Insight   Feb 18, 2020 | By Todd Sasser, Bruker

The Power of Positrons: PET/CT Advances Preclinical Pharmaceutical Research

Preclinical images of mice using Si78 low does PET/CT. (Bruker BioSpin) Credit: Bruker

 
 
Advertisement
 
 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE